Drawing for MANDOS HEALTH

USPTO serial 99691802

MANDOS HEALTH

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ANKRAH, NAAKWAMA S
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with MANDOS HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the prevention and treatment of a variety of ailments and conditions, namely, acute bronchitis, allergies, arthritis, asthma, cancer, cellulitis, cirrhosis, common cold, cold sore, conjunctivitis, cystitis, diabetes, diarrhea, ear infection, fever, fibromyalgia, fungal infection, gastroenteritis, headaches, hemorrhoids, high cholesterol, hyperglycemia, hypoglycemia, indigestion, irritable bowel syndrome, influenza, laryngitis, lyme disease, meningitis, mononucleosis, osteoporosis, pneumonia, pyelonephritis, rosacea, sinusitis, skin abscess, stomach aches, and streptococcal pharyngitisACTIVE—
010Medical devices for the purposes of lowering cholesterolACTIVE—
036Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Intellectual property venture fund management services; Holding company services performed for third parties, namely, investment managementACTIVE—
045Licensing of intellectual propertyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Oct 6, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 11, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 15, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jul 15, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 15, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 9, 2026DOCKASSIGNED TO EXAMINER—
Jul 7, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 9, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance